Filing Flows › Davita (DVA) › U. S. Dialysis and Related Lab Services revenue
Davita (DVA) U. S. Dialysis and Related Lab Services revenue by quarter
Davita's U. S. Dialysis and Related Lab Services revenue was $3.0B in Q3 2026 (third quarter 2026), +0.9% from Q2 2026. Over the last 5 quarters it ranged from $2.9B (Q2 2025) to $3.0B (Q3 2026).
| Quarter | U. S. Dialysis and Related Lab Services revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $3.0B | +0.9% | +2% |
| Q2 2026 | $3.0B | +3% | +4% |
| Q1 2026 | $2.9B | -2% | — |
| Q3 2025 | $3.0B | +2% | — |
| Q2 2025 | $2.9B | — | — |
Q3 2026 at a glance
Davita, Q3 2026: revenue $3.6B (+5% year over year), operating margin 14.0%, net earnings $223M, operating cash flow $519M. The chart follows the revenue to costs, profit and cash.
Questions
What is Davita's U. S. Dialysis and Related Lab Services revenue?
Davita's U.
How has Davita's U. S. Dialysis and Related Lab Services revenue changed?
S. Dialysis and Related Lab Services revenue was $3.0B in Q3 2026 (third quarter 2026), +0.9% from Q2 2026. Over the last 5 quarters it ranged from $2.9B (Q2 2025) to $3.0B (Q3 2026).